Comparison of Urinary CTX-II Levels in Postmenopausal Women with Knee Osteoarthritis with or without Osteoporosis

被引:0
|
作者
Inal, Berrin Bercik [1 ]
Tuhral, Cansel [1 ]
Cetin, Esra [2 ]
Ozgononel, Levant [2 ]
Topkaya, Cigdem [1 ]
Oguz, Gokce [1 ]
Usta, Murat [1 ]
Guvenen, Guvenc [1 ]
机构
[1] Istanbul Training & Res Hosp, Clin Clin Biochem, Istanbul, Turkey
[2] Istanbul Training & Res Hosp, Clin Phys Med & Rehabil, Istanbul, Turkey
来源
关键词
Postmenopause; osteoporosis; osteoarthritis; knee; collagen type I trimeric cross-linked peptide; BONE-MINERAL DENSITY; OSTEO-ARTHRITIS; CARTILAGE DEGRADATION; TELOPEPTIDE FRAGMENTS; INVERSE RELATIONSHIP; HIP OSTEOARTHRITIS; COLLAGEN BREAKDOWN; MARKERS; ASSOCIATION; TOMOGRAPHY;
D O I
10.5336/medsci.2011-24719
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In this study, we investigated a cartilage degradation marker; cross-linked C-terminal telopeptide of collagen, CTX-I (serum) and CTX-II (urine) along with other laboratory variables in postmenopausal women with osteoarthritis (OA) of the knee with/without associated osteoporosis (OP). In addition, we aimed to investigate whether CTX-II which is released into the synovial fluid and systemic circulation and excreted by urine was an effective marker for the diagnosis of OA. Futhermore, we evaluated a possible relation of CTX-II with radiological grades of OA. Material and Methods: Postmenopausal women without any history of OA or OP costituted the control group (n=21). Study Group I consisted of 30 post-menopausal women with primary OA of the knee, and Group II consisted of 14 postmenopausal women with primary OA of the knee along with OP. Group I and Group II were categorized by radiological stages according to Kellgren-Lawrence system as stage 2, stage 3 and stage 4. Results: The control group was not statistically significantly different from Group I, II, or radiologically 2nd, 3rd, 4th stage of OA groups for age, body mass index, duration of menopause or levels of alkaline phosphatase, erythrocyte sedimentation rate, C- reactive protein, osteocalcin, CTX-I and CTX-II. The results of CTX-II values (ng/mmol) of the control and staged groups were as follows; median (25th-75th) level:341 (216-850); 609.34 (363-1072); 492 (319-927); 928 (400-1245) respectively; (p=0.210). Percentage change of median values between the control group and group I, II and radiologically 2nd, 3th, 4th stage of OA groups were 61%+, 80%+, 78%+, 44%,+ 172%+, respectively. Conclusion: CTX-II levels of the control group were similar to those of the knee osteoarthritis patients with or without osteoporosis as well as radiologically graded subgroups, and statistical analysis did not show statistically significant differences. , However, percentage change of median values between the control group and group I, II, and between the control group and radiologically 2nd, 3th, 4th stage of OA groups were significant.
引用
收藏
页码:459 / 465
页数:7
相关论文
共 50 条
  • [1] Can urinary CTX-II be a biomarker for knee osteoarthritis?
    Piti Arunrukthavon
    Danai Heebthamai
    Prapasri Benchasiriluck
    Supinda Chaluay
    Thanainit Chotanaphuti
    Saradej Khuangsirikul
    [J]. Arthroplasty, 2
  • [2] Can urinary CTX-II be a biomarker for knee osteoarthritis?
    Arunrukthavon, Piti
    Heebthamai, Danai
    Benchasiriluck, Prapasri
    Chaluay, Supinda
    Chotanaphuti, Thanainit
    Khuangsirikul, Saradej
    [J]. ARTHROPLASTY, 2020, 2 (01)
  • [3] URINARY CTX-II IS MORE USEFUL IN POSTMENOPAUSAL WOMEN THAN IN MEN TO DETECT RADIOLOGICAL KNEE OA: THE MATSUDAI KNEE OSTEOARTHRITIS SURVEY
    Yamagiwa, H.
    Takahashi, Y.
    Hayami, T.
    Tanishi, N.
    Omori, G.
    Koga, Y.
    Endo, N.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2012, 20 : S85 - S86
  • [4] Strontium Ranelate Decreases the Level of Urinary CTX-II in Patients with Knee Osteoarthritis
    Collette, Julien
    Bruyere, Olivier
    Reginster, Jean-Yves
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S111 - S111
  • [5] STRONTIUM RANELATE DECREASES THE LEVEL OF URINARY CTX-II IN PATIENTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS
    Romas, E.
    [J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 24 - 24
  • [6] Usefulness of urinary CTX-II and NTX-I in evaluating radiological knee osteoarthritis : the Matsudai knee osteoarthritis survey
    Tanishi, Nobuchika
    Yamagiwa, Hiroshi
    Hayami, Tadashi
    Mera, Hisashi
    Koga, Yoshio
    Omori, Go
    Endo, Naoto
    [J]. JOURNAL OF ORTHOPAEDIC SCIENCE, 2014, 19 (03) : 429 - 436
  • [7] SERUM CTX-II DOES NOT MEASURE THE SAME AS URINARY CTX-II
    Luo, Y.
    Bay-Jensen, A.
    Karsdala, M.
    Qvist, P.
    He, Y.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S179 - S179
  • [8] Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women
    Alexandersen, Peter
    Karsdal, M. A.
    Qvist, Per
    Reginster, J-Y.
    Christiansen, Claus
    [J]. BONE, 2007, 40 (01) : 218 - 222
  • [9] Association between urinary CTX-II, serum hyaluronic acid and radiological severity in symptomatic knee osteoarthritis
    Mazieres, B
    Hucher, M
    Zaïm, M
    Garnero, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 484 - 484
  • [10] Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men
    Jordan, K. M.
    Syddall, H. E.
    Garnero, P.
    Gineyts, E.
    Dennison, E. M.
    Sayer, A. A.
    Delmas, P. D.
    Cooper, C.
    Arden, N. K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) : 871 - 877